Recent advances in nonalcholic fatty liver disease

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · see citing works

Obesity is associated with macrophage accumulation in adipose tissue

Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · see citing works

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · see citing works

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675 · see citing works

Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity

Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664 · see citing works

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · see citing works

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345 · see citing works

Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality

Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577 · see citing works

Long-term follow-up of patients with NAFLD and elevated liver enzymes

Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302 · see citing works

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078 · see citing works

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827 · see citing works

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis

Angulo, P., Keach, J. C., Batts, K., & Lindor, K. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,708 · see citing works

Islet cell failure in type 2 diabetes

Prentki, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29103 · Cited by 1,690 · see citing works

Updated definitions of healthy ranges for serum alanine aminotransferase levels

Prati, D., Taioli, E., Zanella, A., Torre, E. D., Butelli, S., Del Vecchio, E., Vianello, L., Zanuso, F., Mozzi, F., Milani, S., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00006 · Cited by 1,445 · see citing works

The Prevalence and Etiology of Elevated Aminotransferase Levels in The United States

Clark, J. M., Brancati, F. L., & Diehl, A. M. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07486.x · Cited by 1,359 · see citing works

A lipidomic analysis of nonalcoholic fatty liver disease

Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338 · see citing works

Leptin regulates proinflammatory immune responses

Loffreda, S., Yang, S., Lin, H., Karp, C. L., Brengman, M. L., Wang, D., Klein, A. S., Bulkley, G. B., Bao, C., Noble, P. W., et al. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.1.57 · Cited by 1,251 · see citing works

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

Mofrad, P., Contos, M., Haque, M., Sargeant, C. C., Fisher, R., Luketic, V., Sterling, R., Shiffman, M., Stravitz, R., & Sanyal, A. (2003) · Hepatology · doi:10.1053/jhep.2003.50229 · Cited by 1,221 · see citing works

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

Osei‐Hyiaman, D., DePetrillo, M. A., Pacher, P., Liu, J., Radaeva, S., Bátkai, S., Harvey-White, J. D., Mackie, K., Offertáler, L., Wang, L., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23057 · Cited by 1,103 · see citing works

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis

Yamaguchi, K., Yang, L., McCall, S. J., Huang, J., Yu, X. X., Pandey, S., Bhanot, S., Monia, B. P., Li, Y.-X., & Diehl, A. M. (2007) · Hepatology · doi:10.1002/hep.21655 · Cited by 1,019 · see citing works

The Inflammatory Syndrome

Wisse, B. E. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141966.69934.21 · Cited by 933 · see citing works

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

Adams, L. A., Sanderson, S. O., Lindor, K. D., & Angulo, P. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.09.012 · Cited by 908 · see citing works

Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway

Feldstein, A. E., Werneburg, N. W., Canbay, A. E., Guicciardi, M. E., Bronk, S. F., Rydzewski, R. M., Burgart, L. J., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20283 · Cited by 833 · see citing works

Histopathology of Pediatric Nonalcoholic Fatty Liver Disease * #

Schwimmer, J. B., Behling, C. A., Newbury, R., Deutsch, R., Nievergelt, C. M., Schork, N. J., & Lavine, J. E. (2005) · Hepatology · doi:10.1002/hep.20842 · Cited by 749 · see citing works

A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease

Bugianesi, E., Gentilcore, E., Manini, R., Natale, S., Vanni, E., Villanova, N., David, E., Rizzetto, M., & Marchesini, G. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41583.x · Cited by 683 · see citing works

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

Wieckowska, A., Zein, N. N., Yerian, L. M., López, R., McCullough, A. J., & Feldstein, A. E. (2006) · Hepatology · doi:10.1002/hep.21223 · Cited by 668 · see citing works

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease†

Villanova, N., Moscatiello, S., Ramilli, S., Bugianesi, E., Magalotti, D., Vanni, E., Zoli, M., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20781 · Cited by 627 · see citing works

LXR-dependent gene expression is important for macrophage survival and the innate immune response.

Joseph, S., Bradley, M. N., Castrillo, A., Bruhn, K. W., Mak, P. A., Pei, L., Hogenesch, J., O'Connell, R., Cheng, G.-H., Saez, E., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.032 · Cited by 601 · see citing works

Activation and Dysregulation of the Unfolded Protein Response in Nonalcoholic Fatty Liver Disease

Puri, P., Mirshahi, F., Cheung, O., Natarajan, R., Maher, J. W., Kellum, J. M., & Sanyal, A. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.10.039 · Cited by 596 · see citing works

Signalling role of adipose tissue: adipokines and inflammation in obesity

Trayhurn, P., & Wood, I. S. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331078 · Cited by 591 · see citing works

The Relation of Markers of Inflammation to the Development of Glucose Disorders in the Elderly

Barzilay, J. I., Abraham, L., Heckbert, S. R., Cushman, M., Kuller, L. H., Resnick, H. E., & Tracy, R. P. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2384 · Cited by 543 · see citing works

Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C†

Sanyal, A. J., Banas, C. A., Sargeant, C., Luketic, V. A., Sterling, R. K., Stravitz, R. T., Shiffman, M. L., Heuman, D. M., COTTERELL, A. H., Fisher, R. A., et al. (2006) · Hepatology · doi:10.1002/hep.21103 · Cited by 521 · see citing works

One-Year Intense Nutritional Counseling Results in Histological Improvement in Patients with Nonalcoholic Steatohepatitis: A Pilot Study

Huang, M. A., Greenson, J. K., Chao, C., Anderson, L., Peterman, D., Jacobson, J. A., Emick, D. M., Lok, A. S.-F., & Conjeevaram, H. S. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41334.x · Cited by 445 · see citing works

A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis

Sanyal, A. J., MOFRAD, P., Contos, M. J., Sargeant, C., Luketic, V. A., Sterling, R. K., Stravitz, R. T., Shiffman, M. L., Clore, J. N., & Mills, A. S. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00457-4 · Cited by 436 · see citing works

Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in Women

Kip, K. E., Marroquin, O. C., Kelley, D. E., Johnson, B. D., Kelsey, S. F., Shaw, L. J., Rogers, W. J., & Reís, S. E. (2004) · Circulation · doi:10.1161/01.cir.0000115514.44135.a8 · Cited by 411 · see citing works

Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis

Contos, M. J., Cales, W., Sterling, R. K., Luketic, V. A., Shiffman, M. L., Mills, A. S., Fisher, R. A., Ham, J. M., & Sanyal, A. J. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.23011 · Cited by 400 · see citing works

Leptin receptor–mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat

Ikejima, K., Takei, Y., Honda, H., Hirose, M., Yoshikawa, M., Zhang, Y., Lang, T., Fukuda, T., Yamashina, S., Kitamura, T., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.32995 · Cited by 385 · see citing works

Influence of Gender, Race, and Ethnicity on Suspected Fatty Liver in Obese Adolescents

Schwimmer, J. B., McGreal, N. M., Deutsch, R., Finegold, M. J., & Lavine, J. E. (2005) · PEDIATRICS · doi:10.1542/peds.2004-1832 · Cited by 376 · see citing works

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

Nair, S., Diehl, A. M., Wiseman, M., Farr, G. H., & Perrillo, R. P. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02025.x · Cited by 369 · see citing works

Surgically-Induced Weight Loss Significantly Improves Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome

Mattar, S. G., Velcu, L. M., Rabinovitz, M., Demetris, A. J., Krasinskas, A. M., Barinas‐Mitchell, E., Eid, G. M., Ramanathan, R. C., Taylor, D. S., & Schauer, P. R. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000179652.07502.3f · Cited by 341 · see citing works

Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis

Kral, J. G., Thung, S. N., Biron, S., Hould, F.-S., Lebel, S., Marceau, S., Simard, S., & Marceau, P. (2004) · Surgery · doi:10.1016/j.surg.2003.10.003 · Cited by 322 · see citing works

Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation.

Castrillo, A., & Tontonoz, P. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.012103.134432 · Cited by 320 · see citing works

Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice†

Yu, X. X., Murray, S. F., Pandey, S., Booten, S. L., Bao, D., Song, X., Kelly, S., Chen, S., McKay, R. A., Monia, B. P., et al. (2005) · Hepatology · doi:10.1002/hep.20783 · Cited by 303 · see citing works

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

the LIDO Study Group and the CYTOL study group, Poynard, T., Ratziu, V., Charlotte, F., Messous, D., Munteanu, M., Imbert‐Bismut, F., Massard, J., Bonyhay, L., Tahiri, M., et al. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-34 · Cited by 297 · see citing works

Pioglitazone Use and Heart Failure in Patients With Type 2 Diabetes and Preexisting Cardiovascular Disease

Erdmann, E., Charbonnel, B. H., Wilcox, R. G., Skene, A. M., Massi‐Benedetti, M., Yates, J., Tan, M. H., Spanheimer, R. G., Standl, E., Dormandy, J., et al. (2007) · Diabetes Care · doi:10.2337/dc07-0717 · Cited by 290 · see citing works

From heterogeneity to plasticity in adipose tissues: Site-specific differences

Prunet‐Marcassus, B., Cousin, B., Caton, D., André, M., Pénicaud, L., & Casteilla, L. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.11.021 · Cited by 280 · see citing works

Role of macrophage tissue infiltration in metabolic diseases

Bouloumié, A., Curat, C. A., Sengenès, C., Lolmède, K., Miranville, A., & Busse, R. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000172571.41149.52 · Cited by 262 · see citing works

Hepatic steatosis is associated with an increased risk of carotid atherosclerosis

Völzke, H. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i12.1848 · Cited by 245 · see citing works

Modulatory effects of dietary lipids on immune system functions

PABLO, M. A. D., & de Cienfuegos, G. Á. (2000) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2000.00875.x · Cited by 241 · see citing works

Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery

Barker, K. B., Palekar, N. A., Bowers, S. P., Goldberg, J. E., Pulcini, J. P., & Harrison, S. A. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00419.x · Cited by 218 · see citing works

Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease

Sanyal, A. J. (2005) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0084 · Cited by 216 · see citing works

Cytokines and the pathogenesis of non-alcoholic steatohepatitis

Diehl, A. M., Li, Z. P., Lin, H., & Yang, S. (2005) · Gut · doi:10.1136/gut.2003.024935 · Cited by 216 · see citing works

Balancing susceptibility to infection and autoimmunity: a role for leptin?

Matarese, G. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02188-9 · Cited by 210 · see citing works

Effects of bariatric surgery on nonalcoholic fatty liver disease: Preliminary findings after 2 years

Furuya, C. K., De Oliveira, C. P. M. S., De Mello, E. S., Faintuch, J., Raskovski, A., Matsuda, M., Vezozzo, D. C. P., Halpern, A., Garrido, A. B., Alves, V. A. F., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04833.x · Cited by 193 · see citing works

A pilot study of orlistat treatment in obese, non‐alcoholic steatohepatitis patients

Harrison, S. A., Fincke, C., Helinski, D., Torgerson, S., & Hayashi, P. H. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02153.x · Cited by 192 · see citing works

Roux‐en‐Y Gastric Bypass Improves Liver Histology in Patients with Non‐Alcoholic Fatty Liver Disease

Clark, J. M., Al-Khuraishi, A., Solga, S. F., Alli, P. M., Diehl, A. M., & Magnuson, T. H. (2005) · Obesity Research · doi:10.1038/oby.2005.140 · Cited by 184 · see citing works

New Insights Regarding the Autoxidation of Polyunsaturated Fatty Acids

Yin, H., & Porter, N. A. (2004) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.170 · Cited by 177 · see citing works

Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease

Choudhury, J., & Sanyal, A. J. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.006 · Cited by 176 · see citing works

Anandamide induces necrosis in primary hepatic stellate cells†‡

Siegmund, S., Uchinami, H., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2005) · Hepatology · doi:10.1002/hep.20667 · Cited by 171 · see citing works

RECURRENCE OF NONALCOHOLIC STEATOHEPATITIS FOLLOWING LIVER TRANSPLANTATION1

Kim, W. R., Poterucha, J. J., Porayko, M. K., Dickson, E. R., Steers, J. L., & Wiesner, R. H. (1996) · Transplantation · doi:10.1097/00007890-199612270-00021 · Cited by 167 · see citing works

Effects of Pioglitazone on Lipoproteins, Inflammatory Markers, and Adipokines in Nondiabetic Patients with Metabolic Syndrome

Szapary, P. O., Bloedon, L. T., Samaha, F. F., Duffy, D., Wolfe, M. L., Soffer, D. E., Reilly, M. P., Chittams, J. L., & Rader, D. J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000195790.24531.4f · Cited by 161 · see citing works

Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non‐alcoholic steatohepatitis

Satapathy, S. K., Sakhuja, P., Malhotra, V., Sharma, B. C., & Sarin, S. K. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04756.x · Cited by 160 · see citing works

Significant correlations between severe fatty liver and risk factors for metabolic syndrome

Hsiao, P., Kuo, K., Shin, S., Yang, Y., Lin, W., Yang, J., Chiu, C., Chuang, W., Tsai, T., & Yu, M. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04698.x · Cited by 152 · see citing works

Resolution of nonalcoholic steatohepatits after gastric bypass surgery

Liu, X., Lazenby, A. J., Clements, R. H., Jhala, N., & Abrams, G. A. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9086-2 · Cited by 149 · see citing works

Determinants of leptin gene expression in fat depots of lean mice

Zhang, Y., Guo, K.-Y., Diaz, P. A., Heo, M., & Leibel, R. L. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00392.2001 · Cited by 137 · see citing works

The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome

Cheung, O., Kapoor, A., Puri, P., Sistrun, S. N., Luketic, V. A., Sargeant, C., Contos, M. J., Shiffman, M. L., Stravitz, R. T., Sterling, R. K., et al. (2007) · Hepatology · doi:10.1002/hep.21803 · Cited by 124 · see citing works

The Fatty Liver and Insulin Resistance

Yki-Järvinen, H., & Westerbacka, J. (2005) · Current Molecular Medicine · doi:10.2174/1566524053766031 · Cited by 120 · see citing works

Glucose induces de novo lipogenesis in rat muscle satellite cells through a sterol-regulatory-element-binding-protein-1c-dependent pathway

Guillet-Deniau, I., Pichard, A., Koné, A., Esnous, C., Nieruchalski, M., Girard, J. R., & Prip‐Buus, C. (2004) · Journal of Cell Science · doi:10.1242/jcs.01069 · Cited by 117 · see citing works

Unsuspected Cirrhosis Discovered During Elective Obesity Operations

Brolin, R. E. (1998) · Archives of Surgery · doi:10.1001/archsurg.133.1.84 · Cited by 117 · see citing works

Prevalence and clinical associations of posttransplant fatty liver disease

Lim, L. G., Cheng, C. L., Wee, A., Lim, S. G., Lee, Y. M., Sutedja, D. S., Costa, M. D., Prabhakaran, K., & Wai, C. T. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01396.x · Cited by 81 · see citing works

Transcription of the Vascular Endothelial Growth Factor Gene in Macrophages Is Regulated by Liver X Receptors

Walczak, R., Joseph, S. B., Laffitte, B. A., Castrillo, A., Pei, L., & Tontonoz, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310587200 · Cited by 71 · see citing works

Deficiency of <i>Cbl-b</i> Gene Enhances Infiltration and Activation of Macrophages in Adipose Tissue and Causes Peripheral Insulin Resistance in Mice

Hirasaka, K., Kohno, S., Goto, J., Furochi, H., Mawatari, K., Harada, N., Hosaka, T., Nakaya, Y., Ishidoh, K., Obata, T., et al. (2007) · Diabetes · doi:10.2337/db06-1768 · Cited by 69 · see citing works

Screening for liver disease using non‐invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia

Ratziu, V., Giral, P., Munteanu, M., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03182.x · Cited by 63 · see citing works

Inflammatory peptides derived from adipose tissue

Rudin, E., & Barzilai, N. (2005) · Immunity & Ageing · doi:10.1186/1742-4933-2-1 · Cited by 57 · see citing works

Diabetes drug pioglitazone (Actos): risk of fracture

Meymeh, R. H., & Wooltorton, E. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.071177 · Cited by 52 · see citing works

Modulation of immune cell function by polyunsaturated fatty acids

Sweeney, B., Puri, P. S., & Reen, D. J. (2005) · Pediatric Surgery International · doi:10.1007/s00383-005-1385-x · Cited by 36 · see citing works

Nonalcoholic Steatohepatitis and the Cardiometabolic Syndrome

Abdeen, M. B., Chowdhury, N. A., Hayden, M. R., & Ibdah, J. A. (2006) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.0197-3118.2006.05523.x · Cited by 26 · see citing works

Coordinate activation of intracellular signaling pathways by insulin-like growth factor-1 and platelet-derived growth factor in rat hepatic stellate cells

Bridle, K. R., Li, L., O’Neill, R., Britton, R. S., & Bacon, B. R. (2006) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2005.12.009 · Cited by 23 · see citing works

Selective Estrogen Receptor Modulator Raloxifene-Associated Aggravation of Nonalcoholic Steatohepatitis

Takamura, T., Shimizu, A., Komura, T., et al. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.6374 · Cited by 20 · see citing works

Rosiglitazone: Possible complications and treatment of non-alcoholic steatohepatitis (NASH)

Henriksen, J. H., & Ring‐Larsen, H. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.10.004 · Cited by 13 · see citing works

The Rosiglitazone Controversy: Meta‐Analysis and the RECORD Study

Liebson, P. R. (2007) · Preventive Cardiology · doi:10.1111/j.1520-037x.2007.06099.x · Cited by 3 · see citing works

Rosiglitazone and Heart Failure: The Controversy and Clinical Implications

Virk, I. S., Ruby, R. S., & Tepper, D. (2007) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2007.06241.x · Cited by 1 · see citing works

The role of mitochondria in the pathogenesis of type 2 diabetes

Patti, M.-E., & Corvera, S. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0027 · Cited by 551 · see citing works

The Etiology of Hepatocellular Carcinoma and Consequences for Treatment

Sanyal, A. J., Yoon, S. K., & Lencioni, R. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-s4-14 · Cited by 517 · see citing works

Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis

Gastaldelli, A., Harrison, S. A., Belfort-Aguilar, R., Hardies, L. J., Balas, B., Schenker, S., & Cusi, K. (2009) · Hepatology · doi:10.1002/hep.23116 · Cited by 285 · see citing works

Spironolactone Improves Glucose and Lipid Metabolism by Ameliorating Hepatic Steatosis and Inflammation and Suppressing Enhanced Gluconeogenesis Induced by High-Fat and High-Fructose Diet

Wada, T., Kenmochi, H., Miyashita, Y., Sasaki, M., Ojima, M., Sasahara, M., Koya, D., Tsuneki, H., & Sasaoka, T. (2010) · Endocrinology · doi:10.1210/en.2009-0869 · Cited by 189 · see citing works

Effect of Bariatric Surgery on Liver Fibrosis

Moretto, M., Kupski, C., da Silva, V. D., Padoin, A. V., & Mottin, C. C. (2012) · Obesity Surgery · doi:10.1007/s11695-011-0559-y · Cited by 110 · see citing works

Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet

Wada, T., Miyashita, Y., Sasaki, M., Aruga, Y., Nakamura, Y., Ishii, Y., Sasahara, M., Kanasaki, K., Kitada, M., Koya, D., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00419.2013 · Cited by 79 · see citing works

Review for "Inhibition of fatty acid synthase with FT ‐4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with NAFLD non‐alcoholic fatty liver disease: results from two early phase randomized trials"

(2020) · doi:10.1111/dom.14272/v2/review3

Review for "Inhibition of fatty acid synthase with FT ‐4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with NAFLD non‐alcoholic fatty liver disease: results from two early phase randomized trials"

(2020) · doi:10.1111/dom.14272/v1/review3

Progress in research of lipogenesis inhibitors for treatment of nonalcoholic fatty liver disease

Yang, L., Li, J.-Z., & Li, M. (2022) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v30.i16.735

Metabolic syndrome predicts the incidence of hepatic steatosis in Koreans

Lee, K. (2010) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2010.02.004 · Cited by 11 · see citing works

The role of the lipogenic pathway in the development of hepatic steatosis

Postic, C., & Girard, J. R. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)74599-3 · Cited by 287 · see citing works